FACTANKER
Altamira Therapeutics Ltd.: xbrl:AdjustedWeightedAverageShares
Value
{"unit": "shares", "value": 910723}
Period
2022-01-01 – 2022-12-31
Status
current
Entity
Altamira Therapeutics Ltd.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001213900-23-040152
Retrieved: 2026-08-19T16:24:25.793555+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…
Cite as: FACTANKER,
https://factanker.com/fact/c1d3120e-9fc3-4bb6-bdc3-7b59424e3a42
History
no predecessors — first report